Cargando…
Pilot Evaluation of the Unsupervised, At-Home Cogstate Brief Battery in ADNI-2
BACKGROUND: There is a need for feasible, scalable assessments to detect cognitive impairment and decline. The Cogstate Brief Battery (CBB) is validated for Alzheimer’s disease (AD) and in unsupervised and bring your own device contexts. The CBB has shown usability for self-completion in the home bu...
Autores principales: | Edgar, Chris J., Siemers, Eric, Maruff, Paul, Petersen, Ronald C., Aisen, Paul S., Weiner, Michael W., Albala, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543269/ https://www.ncbi.nlm.nih.gov/pubmed/34366337 http://dx.doi.org/10.3233/JAD-210201 |
Ejemplares similares
-
Unsupervised Performance of the CogState Brief Battery in the Brain Health Registry: Implications for Detecting Cognitive Decline
por: Banh, T., et al.
Publicado: (2022) -
Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer’s disease
por: Maruff, Paul, et al.
Publicado: (2013) -
Criterion and Construct Validity of the CogState Schizophrenia Battery in Japanese Patients with Schizophrenia
por: Yoshida, Taisuke, et al.
Publicado: (2011) -
Validation of the CogState battery for rapid neurocognitive assessment in Ugandan school age children
por: Bangirana, Paul, et al.
Publicado: (2015) -
Reliability and Validity of the CogState Battery Chinese Language Version in Schizophrenia
por: Zhong, Na, et al.
Publicado: (2013)